Should I buy CareTrust REIT (CTRE) stock or is it too late?

CareTrust REIT · Real Estate · price $39
Logo CareTrust REITSee the full CareTrust REIT (CTRE) profile
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Cantor Fitzgerald63% of its targets hit on this sector (8 calls tested). It aims for $43 (+9.2 %), call made on August 11, 2026, maturing on August 11, 2027 (17 d ago).

The 2 reliable analysts $43+9.2 %
The 3 other firms $47+19 %
How to read it: the 2 reliable firms are not filtered by optimism — 2 aim above the price, 0 below, hence their $43 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on CareTrust REIT

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.
Firm% rightGain vs sectorCallsAims for
Wells Fargo100 %+29.7 %8$47 +19%
RBC Capital86 %+24.0 %7$43 +9%
Keybanc91 %+20.6 %11$40 +2%
Raymond James100 %+19.3 %8$24 -39%
BMO Capital83 %+13.7 %6$47 +19%
In short — Should you invest in CareTrust REIT? Is it too late, still worth it? Analysts are fairly positive (60% buy, median target $43, i.e. +9%), and the most reliable on CTRE targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

  • 60% of analysts rate it a buy (Buy consensus, 5 ratings) — a sign of market conviction.
  • Median price target $43, i.e. +9% from the current price ($39).
  • The most reliable firm on CTRE, Wells Fargo (100% hit rate, 8 scored calls), targets $47 (call made on June 1, 2026, maturing on June 1, 2027) (+19%) in its most recent call, and $41 (call made on November 25, 2025, maturing on November 25, 2026) (+4%) in the one coming due soonest.
  • Pays a dividend (3.5% yield), raised for 6 years — regular income on top of potential upside.

⚠️ Reasons to hesitate

  • The consensus is not unanimous: of 5 ratings, 2 are neutral.
  • A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on CTRE

Median target $43 (+9%) · 5 ratings · Buy consensus

Strong Buy00%
Buy360%
Hold240%
Sell00%
Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in CareTrust REIT now?

We won't decide for you. The facts: 60% of analysts rate it a buy, median target $43 (+9%), and Wells Fargo (most reliable on CTRE, 100%) targets $47. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in CareTrust REIT?

Not according to analysts: the median target ($43) is still +9% above the current price ($39) (most reliable on CTRE: Wells Fargo, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is CareTrust REIT still worth investing in?

It depends on the gap between the price ($39) and its estimated value: analysts target $43 on median (+9%), with 60% buys (most reliable on CTRE: Wells Fargo, 100%). Cross-check with their real reliability on CTRE and the cautions above. Information, not advice.

What's the main risk in buying CTRE?

The consensus is not unanimous: of 5 ratings, 2 are neutral.

→ Go deeper: the full CareTrust REIT profile (consensus, analyst reliability, price target, performance).

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)